Phagenesis raised $42M in a Series D financing led by EQT Life Sciences and co-led by Sectoral for its neurostimulation system to treat swallowing dysfunction.
Amount Raised
$42 Million
Round Type
Series D
Investors
Description
Phagenesis closed a $42 million all-equity investment Series D financing round led by EQT Life Sciences and co-led by Sectoral. The investment will primarily support the commercialization of Phagenesis' neurostimulation system in the United States and deepen penetration in Europe, as well as clinical trials, regulatory activities, and research and development of pipeline products. New investors British Patient Capital, Northern Gritstone, and Aphelion also joined the round.
Quick answer
Phagenesis raised $42 Million in a Series D round, dated March 4, 2024. Investors: Aphelion, Northern Gritstone, British Patient Capital, Sectoral and EQT Life Sciences.
- How much did Phagenesis raise?
- Phagenesis raised $42 Million in a Series D round on March 4, 2024.
- Who invested in Phagenesis?
- Aphelion, Northern Gritstone, British Patient Capital, Sectoral and EQT Life Sciences are named as investors in this round.
- What does Phagenesis do?
- Phagenisis is a Manchester-based medical device company that specializes in the treatment of swallowing disorders.
- Who are the decision-makers at Phagenesis?
- Fundz holds 2 contacts at Phagenesis. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Medical and Medical Device around the same time
Companies in the same sectors as Phagenesis that raised within 45 days of this round, from Fundz verified event records.
- Elucent Medical raised $43M (Series C) on April 10, 2024.
- Neurovalens raised $2.7M (Seed) on April 8, 2024.
- Syntropic Medical raised an undisclosed amount (Funding Round) on April 5, 2024.
- Juniper Biomedical raised $3M (Seed) on April 2, 2024.
- Protembis GmbH raised $32M (Series B) on March 26, 2024.
- Flosonics Medical raised $20M (Series C) on March 19, 2024.
Who to call at Phagenesis, and when
A new round usually means Phagenesis is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Phagenesis raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Phagenesis, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Phagenesis. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Phagenesis raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Phagenesis raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.